Indorama Ventures Public Company Limited (I93A)
Market Open
18 Aug, 06:05
XFRA XFRA Primary XSTU €
0. 56
+0.01
+1.8018%
€
- Market Cap
- P/E Ratio
- Div Yield
97 Volume
0 Eps
€ 0.56
Previous Close Want to track I93A and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
I93A trading today higher at €0.56, an increase of 1.8018% from yesterday's close, completing a monthly decrease of -2.5862% or -€0.01. Over the past 12 months, I93A stock gained 32.0093%.
I93A is not paying dividends to its shareholders.
The last earnings report, released on Feb 24, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XFRA (EUR).
I93A Chart
Indorama Ventures Public Company Limited (I93A) FAQ
What is the stock price today?
The current price is €0.56.
On which exchange is it traded?
Indorama Ventures Public Company Limited is listed on XFRA.
What is its stock symbol?
The ticker symbol is I93A.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, no market cap data is available.
Has Indorama Ventures Public Company Limited ever had a stock split?
No, there has never been a stock split.
Indorama Ventures Public Company Limited Profile
| Chemicals Industry | Materials Sector | Dr. Tommy Leonard CEO | XFRA Exchange | TH1027010R10 ISIN |
| ID Country | 784 Employees | 28 May 2026 Last Dividend | - Last Split | - IPO Date |
Overview
PT Royal Prima Tbk, headquartered in Jakarta, Indonesia, is a provider of private hospital services, established in 2013. The company manages several hospitals across Indonesia, including Royal Prima Medan, Royal Prima Jambi, and RSU Royal Prima Marelan. PT Royal Prima Tbk is recognized for offering a wide range of health services to meet diverse patient needs, exemplifying its commitment to comprehensive healthcare.
Products and Services
PT Royal Prima Tbk provides an extensive array of health services catering to various medical needs:
- Emergency, Outpatient, and Inpatient Services: These services form the core of PT Royal Prima Tbk's offerings, ensuring patients receive timely and appropriate care for both emergencies and scheduled health issues.
- Laboratory, Radiology, and Medical Rehab: Diagnostic and rehabilitative services support patient care through advanced medical technology.
- Pharmacy and MCU (Medical Check-Up): On-site pharmacies and comprehensive health assessments further add to the convenience and holistic care approach.
- Specialized Medical Services: These services span general surgery, internist, VCT (Voluntary Counseling and Testing), ICU (Intensive Care Unit), cardiology, urology, haemodialysis, maternity, paediatric care, endoscopy, cath lab, stroke centre, and trauma centre, ensuring specialized care across various medical disciplines.
- Other Health Services: The company goes beyond basic and specialized care to offer services in acupuncture, anaesthesia, beauty and wellness, dermatology, dental and mouth care, endocrine, digestive, vascular, neurology, ENT (Ear, Nose, and Throat), haematology, nephrology, nutrition, oncology, plastic and paediatric surgery, neurosurgery, obgyn and fertilization, ophthalmology, chemotherapy, psychiatry, psychology, pulmonology, orthopaedic, and paediatric orthopaedic, providing a comprehensive range of healthcare solutions.
Contact Information
Address: Gedung Grand Slipi Tower, Jakarta, Indonesia, 11480
Phone: 62 21 2902 1997
Website: https://www.royalprima.com
